Exhibitions & Events
  • SINOEPG's invitation | Tides USA 2022
    SINOEPG's invitation | Tides USA 2022 April 25,2022.
    Welcome to visit us at SINOPEG's Booth #137 at Tides USA 2022, Boston, USA from 9th to 12th May. SINOPEG has a high-level team with strong technical reserve to research, develop and produce high-quality polyethylene glycol, polyethylene glycol derivatives, block copolymers, anti-diabetic drug side chains, lipid excipients (ingredients for mRNA delivery system), ADC and ProTAC Linker, etc. Please coutact us at [email protected]
    View More
  • Visit SINOPEG at Tides USA 2022, USA
    Visit SINOPEG at Tides USA 2022, USA March 31,2022.
    Welcome to visit us at SINOPEG's Booth #137 at Tides USA 2022, Boston, USA from 9th to 12th May.
    View More
  • Visit SINOPEG at 2022 BIO International Convention, America
    Visit SINOPEG at 2022 BIO International Convention, America March 25,2022.
    Welcome to visit us at SINOPEG's Booth #2351 at 2022 BIO International Convention, San Diego, CA, the USA from 13th to 16th June. SINOPEG is a dynamic science company with professional R&D, Manufacturing and Sales capability. The company is mainly engaged in drug delivery system (DDS) and new medical materials business. Founded in 2011, SINOPEG has a high-level team with strong technical reserve to research, develop and produce high-quality polyethylene glycol, polyethylene glycol derivatives, block copolymers, anti-diabetic drug side chains, lipid excipients (ingredients for mRNA delivery system), ADC and ProTAC Linker, etc. SINOPEG has a technical team led by overseas returned doctors and foreign experts, established good cooperation relations with well-known universities and research institutes in China, such as Xiamen University, Fudan University and the Institute of Chemistry of Chinese Academy of Sciences. The company has the first-class technology development strength, provides services including the reaction, purification, separation and end product analysis and others according to customer needs. SINOPEG holds 24 IP, 19 pending IP, and 6 DMFs that meet FDA requirements. The company has ISO13485 certification. The laboratory and production workshop are designed and built in accordance with the cGMP standard of FDA. We follow the requirements of ICH-Q7A to organize production at scale, to provide high quality polyethylene glycol derivatives products and services to customers globally.
    View More
  • VacCon 2022 | 4th Novel Vaccine R&D and Industrialization Summit
    VacCon 2022 | 4th Novel Vaccine R&D and Industrialization Summit January 11,2022.
    As COVID-19 continuing in 2021, it is necessary to take preventive measures, to accelerate the speed of research and development of COVID-19 vaccines and drugs, to advocate the innovation of new vaccines technologies, and to build the strength to win this epidemic. VacCon 2022, focus on technical breakthrough of the novel vaccines in post COVID-19 era. It will invite 60+ government regulatory experts, scientists and leading entrepreneurs who specialize in vaccine/ neutralizing antibody/ small molecule novel coronavirus drugs. The theme is "Focusing on technical breakthrough of the novel vaccines in post COVID-19 era", which will discuss the latest clinical development, before project approval and R&D in COVID-19 vaccine and drugs, and the leading practice of innovation and process development of mRNA/recombinant protein/adenovirus vector vaccine under different technical paths. SINOPEG, as one of the few companies in China to achieve the commercial production of lipid nanoparticles delivery materials, also attracted a lot of friends to communicate with us at the booth.
    View More
  • SINOPEG Gained Substantial Achievement in CPhI China 2020
    SINOPEG Gained Substantial Achievement in CPhI China 2020 December 22,2020.
    CPhI China 2020 was held successfully in Shanghai, China from Dec. 16th-18th.Sinopeg sent a very professional sales team to participate this exhibition. Our booth Number is W4F21. During the exhibition, many customers visited our booth.  Thanks very much for the support and trust from all friends, customers and partners! We hope we can have close cooperation together, and reach win-win achievement in the future.
    View More
  • SINOPEG Gained Substantial Achievement in CPhI Worldwide 2019
    SINOPEG Gained Substantial Achievement in CPhI Worldwide 2019 2019-11-20
    CPhI Worldwide 2019 was held successfully in Frankfurt, Germany from Nov. 5th-7th. SINOPEG's CEO Dr. Wengui Weng and sales manager Mr. Lingnan Chen attended this exhibition. Our booth Number is 41K60. We SINOPEG was established in 2011, and specilized in PEG derivatives, PEG block-copolymer, side chain of diabetes medications etc.. We are not only maintain the advantage of old products, but also continue to work on the development of new products.   During the exhibition, many customers visited our booth. We had very deep discusstion with our old customers and partners regarding some issues and problems of ongoing projects, and reached agreements for the further programs. Besides, we also received many new potential customers from all over the world. They showed great interest in our products, and made preliminary cooperation intention with us. Thanks very much for the support and trust from all friends, customers and partners! We hope we can have close cooperation together, and reach win-win achievement in the future.
    View More
  • Visit SINOPEG at 2019 CPhI Worldwide, Germany
  • SINOPEG achieved so much in CPhI China 2019
    SINOPEG achieved so much in CPhI China 2019 2019-06-23
    CPhI China 2019 was held successfully in Shanghai, China from June 18th-20th. We Sinopeg sent a very professional sales team to participate this exhibition. Our booth Number is W4F21. During the exhibition, we had very deep disscuion with old partner, and customers from all over the world came to  consult the company's products,we obtained the approval and praise from our customers. Looking forward to see you again next year, CPhI China 2020 in Shanghai.
    View More
first page 1 2 last page

A total of 2 pages

Copyright © XIAMEN SINOPEG BIOTECH CO., LTD. All Rights Reserved.

Home

Products

News

contact